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Background: Halitosis is a condition that affects 50% of adults and one third of patients with chronic kidney disea-
se. The aim of this study was to evaluate oral manifestations and volatile sulfur compounds (VSCs) associated with 
halitosis and quality of life in pre-kidney transplantation candidates. 
Material and methods: The organoleptic test (OT) and halimetry (HA) (before and after cysteine mouthwash) were 
performed in patients with the Oralchroma® device, stimulated (SE) and non-stimulated sialometry (SN), Tongue 
Coating Index (TCI). The OHIP-14 questionnaire was administered to assess the impact of oral health on quality 
of life. 
Results: Fourteen individuals with a mean age of 49.64 ± 13.35 years were evaluated. In the organoleptic test, 
57.14% of the individuals presented halitosis. Oralchroma results showed that dimethyl sulfide was above the 
threshold in 85.71% of the individuals, while hydrogen sulfide and methyl mercaptan were above threshold in 
28.57%; after the use of cysteine, hydrogen sulfide was present in 100% of the cases, dimethyl sulfide in 57.14% 
and methyl mercaptan in 50%. In the non-stimulated sialometry, 57.14% of the individuals presented hyposaliva-
tion and 21.42% in the stimulated. Regarding the tongue coating index, 100% of the individuals presented tongue 
coating, with a mean of 7.64. The assessment of impact of oral health on quality of life showed a negative impact 
in all dimensions. 
Conclusions: Tongue coating, in association with hydrogen sulfide, was the main cause of halitosis in the study 
subjects, and hyposalivation may contribute to higher tongue-coating indices. These oral changes negatively affect 
the quality of life for pre-kidney transplantation patients.
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Introduction
Renal replacement therapy is performed after chronic 
kidney failure in order to reestablish some kidney func-
tions (1). Although renal replacement therapy is perfor-
med to treat chronic kidney disease (CKD), the only 
treatment modality that can reestablish kidney functions 
(2) and restore the quality of life (QOL) of the patients is 
kidney transplantation (KT) (3).
Despite all of the benefits provided by KT to the reci-
pients, there are some comorbidities and oral manifes-
tations that occur due to the use of immunosuppressive 
drugs related to CKD and to the additional medications 
used, for example, hyposalivation and its consequences, 
such as dry month, tongue coating and halitosis (4,5). 
Halitosis is one of the relevant oral manifestations ob-
served in individuals with CKD before and after KT.
There are several methods to measure and to establish 
a diagnosis of halitosis, but Oralchroma® is the only 
halimetry test that can identify the volatile sulfur com-
pounds (VSCs) responsible for halitosis (6,7). The iden-
tification of VSCs is important to the establishment of 
the etiology and treatment of halitosis and, consequently 
(8), improving the QOL of individuals with CKD. 
Available articles evaluating halitosis in KT candidates 
are scarce, especially when it comes to studies using 
Oralchroma®. Therefore, the aim of this study was to 
evaluate oral manifestations and VSCs associated with 
halitosis in KT candidates. 
Material and Methods 
A cross-sectional study was performed in patients with 
chronic kidney disease undergoing hemodialysis in the 
pre-kidney transplantation phase. This study was appro-
ved by the Research Ethics Committee of the institution 
where it was carried out (CAEE 71651517.9.000.5417). 
The inclusion criteria were as follows: age over 18 years 
and diagnosis of chronic kidney disease undergoing he-
modialysis three times a week who agreed to participa-
te in the study and signed the informed consent form. 
The exclusion criteria were as follows: known history 
of head and neck cancer and/or radiotherapy in this re-
gion, current diagnosis of sinusitis, lower respiratory 
tract infection, gastric reflux and/or liver failure, use of 
medications including antihistamines, tricyclic antide-
pressants and antibiotics four weeks prior to the dental 
appointment. 
Before the evaluation, the research subjects were ins-
tructed to go 24 hours without eating spicy foods and/or 
those with a very strong odor and to not drink alcoholic 
beverages. Three hours before the consultation, subjects 
were instructed to avoid brushing their teeth, flossing, 
chewing gum and smoking. At the dental appointment 
time, subjects were instructed to not use cosmetics with 
odors and to not eat or drink for at least one hour before 
the dental appointment time (9).
The organoleptic test was performed by a previously 
trained and calibrated examiner as recommended (10) 
during which the examiner assessed the patient’s breath 
odor 10 cm away from the patient and determined the 
rate as follows: 0 = none, 1 = barely noticeable, 2 = mild 
but clearly noticeable, 3 = moderate, 4 = strong and 5 = 
extremely strong. 
Volatile sulfur compounds were measured using the 
OralChroma™ gas chromatograph (FIS, Itami, Hyo-
go, Japan) according to the instruction manual in two 
separate circumstances. During the first measurement, 
there was no influence from any external factors at the 
beginning of the consultation. The second measurement 
occurred after a cysteine mouthwash (10 ml of 6-mM 
cysteine, pH 7.2) for 30 seconds, as a counter test to in-
duce the formation of VSCs if patients were colonized 
with halitosis-related bacteria (11,12). Thresholds of 112 
for hydrogen sulfide, 26 for methyl mercaptan and 8 for 
dimethyl sulfide were considered (13). 
Stimulated and unstimulated salivary flow were measu-
red (14), and the amount was classified (15) as normal, 
hyposalivation and very low hyposalivation. 
Tongue coating was measured by using the tongue coa-
ting index (16), which divides the tongue into six qua-
drants and each quadrant receives a score from 0 to 2 (0 
being uncoated, 1 lightweight and 2 severe) and totaling 
a maximum score of 12.
The questionnaire OHIP-14 (Oral Health Impact Profi-
le) analyzing the dimensions of oral health impact on 
quality of life was administered and consisted of seven 
dimensions and 14 questions, developed by Slade (17) 
and validated in Portuguese (18). Quality of life factors 
included functional limitation, physical pain, psycholo-
gical discomfort, physical disability, psychological disa-
bility, social disability and handicap.
Descriptive statistics was performed. 
Results
27 individuals with chronic kidney disease undergoing 
hemodialysis were evaluated and of these 14 were in the 
pre-kidney transplant phase and were included in this 
study. They were nine men and five women, with a mean 
age of 49.64 years. The time of hemodialysis of these 
individuals was an average of 48.5 months. 
The organoleptic test showed that 57.14% of individuals 
had halitosis, characterizing them with a noticeable odor 
(average 2.5). The OralChroma test revealed dimethyl 
sulfide in 85.71% of the subjects, while hydrogen sulfi-
de and methyl mercaptan were detected in 28.57%, both 
tests without the cysteine mouthwash. In the cysteine 
post-mouthwash measurement, hydrogen sulfide was 
present in 100% of cases, dimethyl sulfide in 57.14% 
and methyl mercaptan in 50%. 
Unstimulated sialometry showed hyposalivation in 
57.14% of individuals, while stimulated sialometry 
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showed hyposalivation in 21.42%. When assessing the 
tongue coating index, 100% of the individuals presented 
a mean tongue coating of 7.64. 
The mean of the VSC, tongue coating index, organolep-
tic test, unstimulated sialometry and stimulated sialome-
try as well as the percentage of subjects with halitosis, 
tongue coating and unstimulated and stimulated hyposa-
livation are shown in Table 1.
The assessment of impact of oral health on quality of life 
showed a negative impact on the dimensions of functio-
nal limitation, physical disability, social disability and 
handicap and a mean on the dimensions of physical pain, 
psychological discomfort and psychological disability 
(Table 2).
Discussion
Halitosis was observed in individuals with chronic kid-
ney disease by both the organoleptic test and gas chro-
matography. The levels of dimethyl sulfide were high 
before the cysteine mouthwash, while hydrogen sulfide 
and methyl mercaptan levels increased and dimethyl sul-
fide decreased after the cysteine mouthwash, demonstra-
ting that these patients have intraoral halitosis caused by 
tongue coating. Hydrogen sulfide is the main compound 
related to tongue coating (8,19), followed by methyl 
mercaptan (8,20), and tongue coating was also found at 
high rates in more than half of the patients. 
Although dimethyl sulfide is mainly related to systemic 
halitosis (8), its reduction after the cysteine mouthwash 
and the associated increase in hydrogen sulfide shows 
that halitosis in these patients is of intraoral origin. 
Despite the existence of a relationship between syste-
mic halitosis and chronic kidney disease, this is more 
commonly observed in cases where urea levels are de-
compensated (21). Urea levels were stabilized by renal 
replacement therapy in the subjects of our research pro-
ject by hemodialysis three times a week.  Another con-
tributing factor to these results was the assessment that 
Mean ± SD Halitosis (%) Tongue coating (%) Hyposalivation (%)
Age 49,64 ± 13,35 - - -
Hemodialysis time 48,5 ± 32,25 - - -
Hydrogen sulfide BC (ppb) 89,64 ± 122,36 28,57 - -
Methyl mercaptan BC (ppb) 16,29 ± 27,75 28,57 - -
Dimethyl sulfide BC (ppb) 35,43 ± 21,02 85,71 - -
Hydrogen sulfide AC (ppb) 966 ± 564,5 100 - -
Methyl mercaptan AC (ppb) 48,29 ± 72,71 50 - -
Dimethyl sulfide AC (ppb) 21,21 ± 25,62 57,14 - -
Organoleptic test 2,5 ± 1,56 57,14 - -
Tongue coating index 7,64 ± 2,76 - 100 -
Unstimulated flow rate (ml/min) 0,22 ± 0,16 - - 57,14
Stimulated flow rate (ml/min) 1,76 ± 1,16 - - 21,42
Table 1: Mean and standart deviation of age, hydrogen sulfide, methyl mercaptan and dimethyl sulfide (before and after cysteine), or-
ganoleptic test, tongue coating index, unstimulated and stimulated flow rate and percentage of subjects with halitosis, tongue coating 
and hyposalivation.
SD: standart deviation; BC: before cysteine; AC: after cysteine; ppb: part per billion; ml/min: mililiters per minute.
Dimensions OHIP-14 Mean ± SD Classification
Functional limitation 1,28 ± 1,43 Weak
Physical pain 1,95 ± 1,23 Medium
Psychological discomfort 2,11 ± 1,45 Medium
Physical disability 1,13 ± 1,21 Weak
Psychological disability 1,5 ± 1,04 Medium
Social disability 1,15 ± 1,12 Weak
Handicap 1 ± 1,22 Weak 
TOTAL 10,12 ± 7,23 Medium 
Table 2: Mean, standart deviation and classification of dimensions of OHIP-14hal-
itosis, tongue coating and hyposalivation.
SD: standart deviation.
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occurred on days interspersed with hemodialysis, where 
low levels of uremia are expected. 
The presence of VSCs may also be related to a reduced 
salivary flow that promotes halitosis (22) through in-
creased tongue coating (6), which is directly associated 
with hydrogen sulfide (19). Such cases were observed in 
100% of the individuals in our study after cysteine mou-
thwash, probably because our study is unprecedented in 
use of cysteine as halitosis counter test in these patients. 
Tongue coating is primarily caused by poor tongue 
hygiene and may also be associated with reduced sa-
livary flow (6), which was observed in our study that 
all patients showed tongue coating and more than half 
patients (57,14%) having presented hyposalivation (uns-
timulated flow rate). Reduced salivary flow is caused by 
CKD-associated changes in the salivary glands and re-
duced fluid intake in these patients (23,24).
Studies have shown that halitosis can have a negative 
impact on quality of life (25-28), but none of them used 
the OHIP-14 questionnaire and their respective interpre-
tations as it was used in this research. Consistently, we 
observed a negative impact of oral health on quality of 
life in all dimensions of OHIP-14, and this impact may 
be related to both the halitosis and reduced salivary flow 
present in most subjects of this study.
The negative impact of halitosis on quality of life may 
affect the psychological sphere as observed in a pre-
vious study (28) and in our study, mainly when applied 
OHIP-14. The dimensions that were most affected in in-
dividuals with halitosis were psychological discomfort, 
psychological disability and disability. These data are 
important clinically because a simple orientation of ton-
gue hygiene can improve the quality of life of patients 
with tongue coating-related halitosis. 
The reduction in salivary flow also seems to have im-
pacted the quality of life on the functional limitation di-
mension due to the damage that the reduction in saliva 
can cause on chewing, swallowing and speech (23,29) of 
these individuals. In our study, more than half patients 
presented a reduction in unstimulated salivary flow, re-
presenting an alert for health professionals, that should 
be aware of the signs of dry mouth, halitosis and the 
possible complaint of xerostomia for the institution of 
the appropriate therapy. 
Tongue coating associated with the production of hydro-
gen sulfide is the main cause of halitosis in individuals 
with chronic kidney disease in the pre-kidney transplant 
phase. Hyposalivation may be a factor that contributes 
to higher levels of tongue coating and consequently to 
the occurrence of halitosis in these individuals. These 
oral changes may contribute to discomfort and psycho-
logical disability and negatively affect the quality of life 
before kidney transplantation. 
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